Ramon Andrade de Mello
AuthID: R-00F-MXH
31
TITLE: Outcomes of allogeneic stem cell transplantation among patients with acute myeloid leukemia presenting active disease: Experience of a single European Comprehensive Cancer Center Full Text
AUTHORS: Ramon Andrade B Bezerra de Mello; Carlos Pinho Vaz; Rosa Branca; Fernando Campilho; Maria Rosales; Susana Roncon; Antonio Campos Junior;
PUBLISHED: 2016, SOURCE: REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, VOLUME: 62, ISSUE: 7
AUTHORS: Ramon Andrade B Bezerra de Mello; Carlos Pinho Vaz; Rosa Branca; Fernando Campilho; Maria Rosales; Susana Roncon; Antonio Campos Junior;
PUBLISHED: 2016, SOURCE: REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, VOLUME: 62, ISSUE: 7
INDEXED IN: 
WOS
WOS32
TITLE: Definitive chemoradiotherapy for squamous head and neck cancer: cisplatin versus carboplatin? A meta-analysis
AUTHORS: Pedro Nazareth Aguiar; Hakaru Tadokoro; Gislaine Fernandes da Silva; Mayndra Mychelle Landgraf; Carmelia Maria Noia Barreto; Bruno Andraus Filardi; Gilberto de Lima Lopes; Pedro Oliveira; Ramon Andrade de Mello;
PUBLISHED: 2016, SOURCE: FUTURE ONCOLOGY, VOLUME: 12, ISSUE: 23
AUTHORS: Pedro Nazareth Aguiar; Hakaru Tadokoro; Gislaine Fernandes da Silva; Mayndra Mychelle Landgraf; Carmelia Maria Noia Barreto; Bruno Andraus Filardi; Gilberto de Lima Lopes; Pedro Oliveira; Ramon Andrade de Mello;
PUBLISHED: 2016, SOURCE: FUTURE ONCOLOGY, VOLUME: 12, ISSUE: 23
INDEXED IN: WOS
WOS33
TITLE: EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer
AUTHORS: Ramon Andrade de Mello; Davi J J Liu; Pedro N Aguiar; Hakaru Tadokoro;
PUBLISHED: 2016, SOURCE: RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, VOLUME: 11, ISSUE: 4
AUTHORS: Ramon Andrade de Mello; Davi J J Liu; Pedro N Aguiar; Hakaru Tadokoro;
PUBLISHED: 2016, SOURCE: RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, VOLUME: 11, ISSUE: 4
INDEXED IN: WOS
WOS34
TITLE: Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies
AUTHORS: Ines de Paula Costa Monteiro; Pedro Madureira; Alessandro de Vasconscelos; Daniel Humberto Pozza ; Ramon Andrade de Mello;
PUBLISHED: 2015, SOURCE: PHARMACOGENOMICS, VOLUME: 16, ISSUE: 3
AUTHORS: Ines de Paula Costa Monteiro; Pedro Madureira; Alessandro de Vasconscelos; Daniel Humberto Pozza ; Ramon Andrade de Mello;
PUBLISHED: 2015, SOURCE: PHARMACOGENOMICS, VOLUME: 16, ISSUE: 3
35
TITLE: Nivolumab for advanced squamous cell lung cancer: what are the next steps? Full Text
AUTHORS: Ramon Andrade de Mello; Ines Pousa; Deolinda Pereira;
PUBLISHED: 2015, SOURCE: LANCET ONCOLOGY, VOLUME: 16, ISSUE: 3
AUTHORS: Ramon Andrade de Mello; Ines Pousa; Deolinda Pereira;
PUBLISHED: 2015, SOURCE: LANCET ONCOLOGY, VOLUME: 16, ISSUE: 3
36
TITLE: Treating operable patients with gastric cancer: Macdonald's protocol versus adjuvant chemotherapy
AUTHORS: Pedro Nazareth Aguiar; Hakaru Tadokoro; Nora Manoukian Forones; Ramon Andrade de Mello;
PUBLISHED: 2015, SOURCE: FUTURE ONCOLOGY, VOLUME: 11, ISSUE: 16
AUTHORS: Pedro Nazareth Aguiar; Hakaru Tadokoro; Nora Manoukian Forones; Ramon Andrade de Mello;
PUBLISHED: 2015, SOURCE: FUTURE ONCOLOGY, VOLUME: 11, ISSUE: 16
37
TITLE: MMR deficiency may lead to a high immunogenicity and then an improvement in anti-PD-1 efficacy for metastatic colorectal cancer
AUTHORS: Pedro Nazareth Aguiar; Hakaru Tadokoro; Nora Manoukian Forones; Ramon Andrade de Mello;
PUBLISHED: 2015, SOURCE: IMMUNOTHERAPY, VOLUME: 7, ISSUE: 11
AUTHORS: Pedro Nazareth Aguiar; Hakaru Tadokoro; Nora Manoukian Forones; Ramon Andrade de Mello;
PUBLISHED: 2015, SOURCE: IMMUNOTHERAPY, VOLUME: 7, ISSUE: 11
38
TITLE: Role of mesenchymal-epithelial transition amplification in resistance to anti-epidermal growth factor receptor agents
AUTHORS: Raffaele Califano; Floriana Morgillo; Ramon Andrade De Mello; Giannis Mountzios;
PUBLISHED: 2015, SOURCE: ANNALS OF TRANSLATIONAL MEDICINE, VOLUME: 3, ISSUE: 6
AUTHORS: Raffaele Califano; Floriana Morgillo; Ramon Andrade De Mello; Giannis Mountzios;
PUBLISHED: 2015, SOURCE: ANNALS OF TRANSLATIONAL MEDICINE, VOLUME: 3, ISSUE: 6
INDEXED IN: 
Scopus WOS
Scopus WOS39
TITLE: Cetuximab Plus Platinum-Based Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Retrospective Study in a Single Comprehensive European Cancer Institution Full Text
AUTHORS: Ramon Andrade de Mello; Sandra Geros; Marcos Pantarotto Alves; Filipa Moreira; Isabel Avezedo; Jose Dinis;
PUBLISHED: 2014, SOURCE: PLOS ONE, VOLUME: 9, ISSUE: 2
AUTHORS: Ramon Andrade de Mello; Sandra Geros; Marcos Pantarotto Alves; Filipa Moreira; Isabel Avezedo; Jose Dinis;
PUBLISHED: 2014, SOURCE: PLOS ONE, VOLUME: 9, ISSUE: 2
40
TITLE: BRAF and MEK Gene Rearrangements in Melanoma: Implications for Targeted Therapy
AUTHORS: Pedro Madureira; Ramon Andrade de Mello;
PUBLISHED: 2014, SOURCE: MOLECULAR DIAGNOSIS & THERAPY, VOLUME: 18, ISSUE: 3
AUTHORS: Pedro Madureira; Ramon Andrade de Mello;
PUBLISHED: 2014, SOURCE: MOLECULAR DIAGNOSIS & THERAPY, VOLUME: 18, ISSUE: 3
